Pathways leading to phosphorylation of P450c17 and to the posttranslational regulation of androgen biosynthesis

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2667-2677

  Meng, Kian Tee ^a   Dong, Qing ^a   Miller, Walter L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ANDROGEN; CALMODULIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450C17; LYASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE KINASE; RHO KINASE; SMALL INTERFERING RNA;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MICROARRAY ANALYSIS; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS;

ANDROGENS; ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; STEROID 17-ALPHA-HYDROXYLASE; TRANSFECTION;

EID: 42449129236     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1527     Document Type: Article

References (66)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
2. Dunaif A, Thomas A 2001 Current concepts in the polycystic ovary syndrome. Annu Rev Med 52:401-419
3. Lachelin GC, Judd HL, Swanson SC, Hauck ME, Parker DC, Yen SS 1982 Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease. J Clin Endocrinol Metab 55:768-773
4. Rittmaster RS, Thompson DL 1990 Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 70:1096-1102
5. Hoffman DI, Klove K, Lobo RA 1984 The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 42:76-81
6. Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA 1989 Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320:559-565
7. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
8. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318
9. Voutilainen R, Tapanainen J, Chung B, Matteson KJ, Miller WL 1986 Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17α-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 63:202-207
10. Stocco DM 2001 StAR protein and the regulation of steroid hormone biosynthesis. Ann Rev Physiol 63:193-213
11. Miller WL 2007 StAR search: what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol 21:589-601
12. Miller WL, Auchus RJ, Geller DH 1997 The regulation of 17,20 lyase activity. Steroids 62:133-142
13. 17,20 lyase cytochrome P450. J Biol Chem 259:3971-3976
14. Chung B, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shivley JE, Miller WL 1987 Cytochrome P450c17 (steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 84:407-411
15. Zuber MX, Simpson ER, Waterman MR 1986 Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS-1) cells. Science 234:1258-1261
16. 106→ Pro causes 17α-hydroxylase deficiency. J Biol Chem 266:15992-15998
17. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR, Rainey WE 2000 Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 53:739-747
18. Apter D, Pakarinen A, Hammond GL, Vihko R 1979 Adrenocortical function in puberty. Acta Paediatr Scand 68:599-604
19. Arlt W, Martens JWM, Song M, Wang JT, Auchus RJ, Miller WL 2002 Molecular evolution of adrenarche: structural and functional analysis of P450c17 from four primate species. Endocrinology 143:4665-4672
20. Endoh A, Kristiansen SB, Casson PR, Buster JE, Hornsby PJ 1996 The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 81:3558-3565
21. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, Rainey WE 1998 Adrenarche results from development of a 3β-hydroxysteroid dehydrogenasedeficient adrenal reticularis. J Clin Endocrinol Metab 83:3695-3701
22. Miller WL 2005 Regulation of steroidogenesis by electron transfer. Endocrinology 146:2544-2550
23. Yanagibashi K, Hall PF 1986 Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem 261:8429-8433
24. 106 and P450 reductase. Endocrinology 132:2498-2506
25. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158-3165
26. 5. Mol Endocrinol 13:167-175
27. Zhang L, Rodriguez H, Ohno S, Miller WL 1995 Serine phosphorylation of human P450c17 increases 17,20 lyase activity: implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci USA 92:10619-10623
28. Biason-Lauber A, Zachmann M, Schoenle EJ 2000 Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche. Endocrinology 141:1446-1454
29. Pandey AV, Mellon SH, Miller WL 2003 Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem 278:2837-2844
30. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
31. Watson RT, Kanzaki M, Pessin JE 2004 Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25:177-204
32. White MF, Yenush L 1998 The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Topics Microbiol Immunol 228:179-208
33. Virkamaki A, Ueki K, Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
34. Bollag GE, Roth RA, Beaudoin J, Mochley-Rosen D, Koshland Jr DE 1986 Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 83:5822-5824
35. Stadtmauer L, Rosen OM 1986 Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor. J Biol Chem 261:3402-3407
36. Takayama S, White MF, Kahn CR 1988 Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263:3440-3447
37. Chin JE, Dickens M, Tavare JM, Roth RA 1993 Overexpression of protein kinase C isozymes α, βI, γ and ε in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J Biol Chem 268:6338-6347
38. Dunaif A, Xia J, Book CB, Schenker E, Tang Z 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 96:801-810
39. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF 2001 Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107:181-189
40. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A 2005 Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288:E1047-E1054
41. Auchus RJ, Geller DH, Lee TC, Miller WL 1998 The regulation of human P450c17 activity: relationship to premature adrenarche and the polycystic ovary syndrome. Trends Endocrinol Metab 9:47-50
42. Munir I, Yen H-W, Geller DH, Torbati D, Bierden RM, Weitsman SR, Agarwal AK, Magoffin DA 2004 Insulin augmentation of 17α-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 145:175-183
43. Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A 2006 Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55:751-759
44. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, LaRocca RV 1990 Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 50:5488-5496
45. Staels B, Hum DW, Miller WL 1993 Regulation of steroidogenesis in NCIH295 cells: a cellular model of the human fetal adrenal. Mol Endocrinol 7:423-433
46. Rodriguez H, Hum DW, Staels B, Miller WL 1997 Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. J Clin Endocrinol Metab 82:365-371
47. ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 404:118-124
48. Brock BJ, Waterman MR 1999 Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 38:1598-1606
49. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, van Vliet G, Sack J, Flück CE, Miller WL 2005 Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76:729-749
50. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L 2003 A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406
51. 5 and by serine phosphorylation of P450c17. J Biol Chem 280:13265-13271
52. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S 2002 The protein kinase complement of the human genome. Science 298:1912-1934
53. Anonymous, Design and performance of the Gene Chip Human Genome U133 Plus 2.0 and Human Genome U133A 2.0 arrays. Affymetrix Technical Note: www.affymetrix.com
54. Efimova T, Broome AM, Eckert RL 2003 A regulatory role for p38δ MAPK in keratinocyte differentiation. Evidence for p38 -ERK1/2 complex formation. J Biol Chem 278:34277-34285
55. Beale EG, Hammer RE, Antoine B, Forest C 2004 Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 15:129-135
56. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Oxley KM, Wyllie DH, Polgar T, Harte M, O'Neill LA, Qwarnstrom EE, Dower SK 2004 Human tribbles, a protein family controlling nitrogen-activated protein kinase cascades. J Biol Chem 279:42703-42708
57. Ikenoya M, Hidaka H, Hosoya T, Suzuki M, Yamamoto N, Sasaki Y 2002 Inhibition of Rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem 81:9-16
58. Parker PJ, Parkinson SJ 2001 AGC protein kinase phosphorylation and protein kinase C. Biochem Soc Trans 29:860-863
59. Dvorsky R, Blumenstein L, Vetter IR, Ahmadian MR 2004 Structural insights into the interaction of ROCK1 with the switch regions of RhoA. J Biol Chem 279:7098-7104
60. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, Inagaki M, Kaibuchu K 1999 Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147:1023-1038
61. Sumi T, Matsumoto K, Shibuya A, Nakamura T 2001 Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-binding kinase α. J Biol Chem 276:23092-23096
62. Auchus RJ, Miller WL 1999 Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169-1182
63. Souter I, Munir I, Mallick P, Weitsman SR, Geller DH, Magoffin DA 2006 Mutagenesis of putative serine-threonine phosphorylation sites proximal to Arg255 of human cytochrome P450c17 does not selectively promote its 17,20 lyase activity. Ferti Steril 85(Suppl 1):1290-1299
64. Nelson-DeGrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimball SR, Strauss III JF, McAllister JM 2005 Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol 19:379-390
65. Wettschureck N, Offermanns S 2002 Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med 80:629-638
66. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A 2002 Active Rho kinase (ROK-α) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277:6214-6222